ATE267018T1 - Verwendung von peptidverbindungen zur behandlung von sle - Google Patents

Verwendung von peptidverbindungen zur behandlung von sle

Info

Publication number
ATE267018T1
ATE267018T1 AT98830310T AT98830310T ATE267018T1 AT E267018 T1 ATE267018 T1 AT E267018T1 AT 98830310 T AT98830310 T AT 98830310T AT 98830310 T AT98830310 T AT 98830310T AT E267018 T1 ATE267018 T1 AT E267018T1
Authority
AT
Austria
Prior art keywords
peptide compounds
treat sle
sle
treat
thr
Prior art date
Application number
AT98830310T
Other languages
English (en)
Inventor
Maria Marino
Maria Rossi
Giorgio Fassina
Original Assignee
Tecnogen Scpa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tecnogen Scpa filed Critical Tecnogen Scpa
Application granted granted Critical
Publication of ATE267018T1 publication Critical patent/ATE267018T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/10—Peptides having 12 to 20 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
AT98830310T 1998-05-21 1998-05-21 Verwendung von peptidverbindungen zur behandlung von sle ATE267018T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP98830310A EP0958829B1 (de) 1998-05-21 1998-05-21 Verwendung von Peptidverbindungen zur Behandlung von SLE

Publications (1)

Publication Number Publication Date
ATE267018T1 true ATE267018T1 (de) 2004-06-15

Family

ID=8236657

Family Applications (1)

Application Number Title Priority Date Filing Date
AT98830310T ATE267018T1 (de) 1998-05-21 1998-05-21 Verwendung von peptidverbindungen zur behandlung von sle

Country Status (7)

Country Link
US (1) US6303577B1 (de)
EP (1) EP0958829B1 (de)
JP (1) JP2000053580A (de)
AT (1) ATE267018T1 (de)
CA (1) CA2270687A1 (de)
DE (1) DE69823981T2 (de)
ES (1) ES2218796T3 (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MEP42108A (en) 1998-10-23 2011-02-10 Kiren Amgen Inc Dimeric thrombopoietin peptide mimetics binding to mp1 receptor and having thrombopoietic activity
US7488590B2 (en) 1998-10-23 2009-02-10 Amgen Inc. Modified peptides as therapeutic agents
US6916904B2 (en) 2002-04-24 2005-07-12 Zolaris Biosciences, Llc Inhibition of immune complex formation
WO2006036834A2 (en) 2004-09-24 2006-04-06 Amgen Inc. MODIFIED Fc MOLECULES
US8008453B2 (en) 2005-08-12 2011-08-30 Amgen Inc. Modified Fc molecules
TW200827367A (en) 2006-10-26 2008-07-01 Kyowa Hakko Kogyo Kk A therapeutic agent for irritable bowel syndrome
EP3134732A2 (de) * 2014-04-24 2017-03-01 Alnylam Pharmaceuticals, Inc. Verfahren und zusammensetzungen zum nachweis von anti-wirkstoff-antikörpern

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU7525796A (en) * 1995-10-30 1997-05-22 Merck & Co., Inc. Novel inhibitors of peptide binding to mhc class ii proteins

Also Published As

Publication number Publication date
US6303577B1 (en) 2001-10-16
DE69823981T2 (de) 2005-05-25
CA2270687A1 (en) 1999-11-21
DE69823981D1 (de) 2004-06-24
EP0958829B1 (de) 2004-05-19
JP2000053580A (ja) 2000-02-22
EP0958829A1 (de) 1999-11-24
ES2218796T3 (es) 2004-11-16

Similar Documents

Publication Publication Date Title
DK0842934T3 (da) 5-HT1F agonister
DE69729946D1 (de) Verwendung von cyclooxygenase-2 inhibitoren zur behandlung und verbeugung von neoplasia
MX9302932A (es) Nuevas 4-aza-5&-androstan-3-onas 7b-substituidas como inhibidores de la5&-reductasa.
DE59308021D1 (de) Imidazolidin-Derivate
FI890311A0 (fi) Kemiska foereningar.
NO944406D0 (no) Nye 7 se inhibitorer
DE69911935D1 (de) Granulatimide-derivate zur behandlung von krebs
PT882726E (pt) Carbazol-carboxamidas como agonistas 5-ht1f
NO984950L (no) Forbindelser med veksthormonfrigj°rende egenskaper
ATE267018T1 (de) Verwendung von peptidverbindungen zur behandlung von sle
EA199900534A1 (ru) Имидазопиридазины
DE69931487D1 (de) Verwendung von apomorphin zur behandlung der vorzeitigen ejakulation
BR9713176A (pt) Benzotiofenos amorfos,métodos de preparação e métodos de uso
DE59109225D1 (de) Verwendung von pyridylmethylsulfinyl-1h-benzimidazol derivaten zur behandlung durch helicobacter verursachter erkrankungen
ATE222896T1 (de) Substituierte thiazoline und ihre verwendung zur bekämpfung von tierischen schädlingen
DE69940971D1 (de) Verwendung von erythropoietin zur behandlung von primärer hämochromatosen
DE60000658D1 (de) Zusammensetzung zur behandlung von psoriasis
ATE213413T1 (de) Verwendung von 3-(4-hexyloxy-1,2,5-thiadiazol-3- yl)-1,2,5,6-tetrahydro-1-methylpyridin (xanomelin) zur behandlung von bipolaren störungen
PT1104419E (pt) Derivados de azabicicloheptano substituidos no azoto sua preparacao e utilizacao
DE50003481D1 (de) Verwendung von schmutzablösenden formulierungen zur behandlung von oberflächen
DE69926996D1 (de) Verwendung von riluzol zur behandlung der retinalischemie
DE68926222D1 (de) Verwendung von 1,2,3,4-Tetrahydroacridinen zur Behandlung von AIDS, sowie Verbindungen
BR9807920A (pt) Processos para tratamento de uma demência em um sujeito e para prevenção de uma demência
DE69807990D1 (de) Verfahren zur Stabilisierung von 4,6-Diaminoresorcin und dessen Salzen
ATE137973T1 (de) Phospholipide zur behandlung der multiplen sklerose

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 0958829

Country of ref document: EP

REN Ceased due to non-payment of the annual fee